FierceBiotech

FDA approves Adempas to treat pulmonary hypertension

The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Pulmonary hypertension is caused by abnormally high blood pressure in ...
Finanznachrichten

Bayer to Present Data Investigating Recently Approved Adempas (riociguat) Tablets

Male patients are not enrolled in the Adempas REMS Program. Female patients of reproductive potential must comply with the pregnancy testing and contraception requirements. Pharmacies must be ...
Business Insider

Bayer to Present Pulmonary Arterial Hypertension Data at the 2017 Annual Meeting of the American College of Chest Physicians

WHIPPANY, N.J., Oct. 24, 2017 /PRNewswire/ -- Bayer announced today that data from its pulmonary disease franchise will be presented in scientific sessions at the 2017 annual meeting of the American ...
Monthly Prescribing Reference

First-in-Class Drug for Pulmonary Hypertension Approved

ADEMPAS (riociguat) tablets Bayer HealthCare announced that the FDA has approved Adempas (riociguat) tablets, a first-in-class drug, for the treatment of persistent/recurrent chronic thromboembolic ...
Pharmabiz

Bayer phase IV REPLACE study in PAH patients who had transitioned to Adempas after insufficient response to PDE5 inhibitors meets primary endpoint

Bayer announced results from the phase IV REPLACE (Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy) study, in which intermediate-risk adult patients with pulmonary ...
Drug Store News

FDA approves Adempas to treat pulmonary hypertension

SILVER SPRING, Md. — The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high ...
clinicaladvisor.com

FDA approves Adempas for pulmonary hypertension

HealthDay News — The FDA has approved riociguat (Adempas, Bayer) to treat chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) of various causes. The drug is ...